These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31212712)

  • 1. CD28 Autonomous Signaling Up-Regulates C-Myc Expression and Promotes Glycolysis Enabling Inflammatory T Cell Responses in Multiple Sclerosis.
    Kunkl M; Sambucci M; Ruggieri S; Amormino C; Tortorella C; Gasperini C; Battistini L; Tuosto L
    Cells; 2019 Jun; 8(6):. PubMed ID: 31212712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytes.
    Camperio C; Muscolini M; Volpe E; Di Mitri D; Mechelli R; Buscarinu MC; Ruggieri S; Piccolella E; Salvetti M; Gasperini C; Battistini L; Tuosto L
    Immunol Lett; 2014; 158(1-2):134-42. PubMed ID: 24412596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD28 Individual Signaling Up-regulates Human IL-17A Expression by Promoting the Recruitment of RelA/NF-κB and STAT3 Transcription Factors on the Proximal Promoter.
    Kunkl M; Mastrogiovanni M; Porciello N; Caristi S; Monteleone E; Arcieri S; Tuosto L
    Front Immunol; 2019; 10():864. PubMed ID: 31068940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD28 Autonomous Signaling Orchestrates IL-22 Expression and IL-22-Regulated Epithelial Barrier Functions in Human T Lymphocytes.
    Kunkl M; Amormino C; Frascolla S; Sambucci M; De Bardi M; Caristi S; Arcieri S; Battistini L; Tuosto L
    Front Immunol; 2020; 11():590964. PubMed ID: 33178223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4+ T lymphocytes of patients with relapsing-remitting multiple sclerosis.
    Ahmadian-Elmi M; Bidmeshki Pour A; Naghavian R; Ghaedi K; Tanhaei S; Izadi T; Nasr-Esfahani MH
    Immunogenetics; 2016 Jan; 68(1):43-54. PubMed ID: 26563334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-independent Th2 cell differentiation by stimulation of CD28: regulation via IL-4 gene expression and mitogen-activated protein kinase activation.
    Skapenko A; Lipsky PE; Kraetsch HG; Kalden JR; Schulze-Koops H
    J Immunol; 2001 Apr; 166(7):4283-92. PubMed ID: 11254680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.
    Appleman LJ; van Puijenbroek AA; Shu KM; Nadler LM; Boussiotis VA
    J Immunol; 2002 Mar; 168(6):2729-36. PubMed ID: 11884439
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Zhang S; Li J; Xie P; Zang T; Shen H; Cao G; Zhu Y; Yue Z; Li Z
    Rejuvenation Res; 2019 Apr; 22(2):138-145. PubMed ID: 29932015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CD28 signaling pathway regulates glucose metabolism.
    Frauwirth KA; Riley JL; Harris MH; Parry RV; Rathmell JC; Plas DR; Elstrom RL; June CH; Thompson CB
    Immunity; 2002 Jun; 16(6):769-77. PubMed ID: 12121659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration.
    La Rocca C; Carbone F; De Rosa V; Colamatteo A; Galgani M; Perna F; Lanzillo R; Brescia Morra V; Orefice G; Cerillo I; Florio C; Maniscalco GT; Salvetti M; Centonze D; Uccelli A; Longobardi S; Visconti A; Matarese G
    Metabolism; 2017 Dec; 77():39-46. PubMed ID: 29132538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapsing-Remitting Multiple Sclerosis Is Characterized by a T Follicular Cell Pro-Inflammatory Shift, Reverted by Dimethyl Fumarate Treatment.
    Cunill V; Massot M; Clemente A; Calles C; Andreu V; Núñez V; López-Gómez A; Díaz RM; Jiménez MLR; Pons J; Vives-Bauzà C; Ferrer JM
    Front Immunol; 2018; 9():1097. PubMed ID: 29896193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, Bcl-xL, and IL-2 expression in primary human CD4 T lymphocytes.
    Parry RV; Rumbley CA; Vandenberghe LH; June CH; Riley JL
    J Immunol; 2003 Jul; 171(1):166-74. PubMed ID: 12816995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion of CD4+CD28- T cells producing high levels of interferon-{gamma} in peripheral blood of patients with multiple sclerosis.
    Miyazaki Y; Iwabuchi K; Kikuchi S; Fukazawa T; Niino M; Hirotani M; Sasaki H; Onoé K
    Mult Scler; 2008 Sep; 14(8):1044-55. PubMed ID: 18573819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged TCR/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin.
    Colombetti S; Basso V; Mueller DL; Mondino A
    J Immunol; 2006 Mar; 176(5):2730-8. PubMed ID: 16493028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways.
    Jacobs SR; Herman CE; Maciver NJ; Wofford JA; Wieman HL; Hammen JJ; Rathmell JC
    J Immunol; 2008 Apr; 180(7):4476-86. PubMed ID: 18354169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis.
    Ruocco G; Rossi S; Motta C; Macchiarulo G; Barbieri F; De Bardi M; Borsellino G; Finardi A; Grasso MG; Ruggieri S; Gasperini C; Furlan R; Centonze D; Battistini L; Volpe E
    Clin Sci (Lond); 2015 Aug; 129(4):291-303. PubMed ID: 25700150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis.
    Lassmann H
    Front Immunol; 2018; 9():3116. PubMed ID: 30687321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In active relapsing-remitting multiple sclerosis, effector T cell resistance to adaptive T(regs) involves IL-6-mediated signaling.
    Schneider A; Long SA; Cerosaletti K; Ni CT; Samuels P; Kita M; Buckner JH
    Sci Transl Med; 2013 Jan; 5(170):170ra15. PubMed ID: 23363979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXP3 induced by CD28/B7 interaction regulates CD25 and anergic phenotype in human CD4+CD25- T lymphocytes.
    Scottà C; Soligo M; Camperio C; Piccolella E
    J Immunol; 2008 Jul; 181(2):1025-33. PubMed ID: 18606654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-150 impairs inflammatory cytokine production by targeting ARRB-2 after blocking CD28/B7 costimulatory pathway.
    Sang W; Wang Y; Zhang C; Zhang D; Sun C; Niu M; Zhang Z; Wei X; Pan B; Chen W; Yan D; Zeng L; Loughran TP; Xu K
    Immunol Lett; 2016 Apr; 172():1-10. PubMed ID: 26549736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.